Home
How it works
- The Score
- Pre-Check
- Priors
- Pre-Reporting
- Efficiency
- Confidence
- Integration
Clinical Evidence
- Case of the Week
Try MammoScreen
About
- Blog
- Tradeshows
- FAQ
- Contact
Request a Demo

Blog

Discover the latest News of Mammoscreen® 2D&3D

Sign up for News & Updates

Home
About
Blog

Blog

Nothing found.

Sign up for News & Updates

SEARCH

CATEGORIES

Company news
Scientific Publications
Case of the week
AI implementation
AI fundamentals
AI exploration & feasibility
AI future trends
AI & radiology daily challenges

RECENT POST

RamSoft and Therapixel Announce Commercial Partnership to Deliver Integrated AI-Powered Breast Imaging Solution June 5, 2025
MammoScreen® Breast AI Adopted by Mayo Clinic for Radiology Use May 5, 2025
Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network April 3, 2025
Case of the week (week 3, 2025) January 17, 2025
Case of the week (week 2, 2025) January 8, 2025

MammoScreen^® is a product of:

MammoScreen^® is a registered trademark of Therapixel Inc.

Menu

How it Works
Clinical Evidence
Try MammoScreen
About
FAQ
Contact

Extras

Legal info
Privacy Policy
Sitemap

MammoScreen® is 510(k) FDA cleared for FFDM (2D) and DBT (3D).

Contact

1700 W Irving Park Road ST. 209A

Chicago – IL 60613
USA

© 2023 Therapixel | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences